Successful Targeting and Disruption of an Integrated Reporter Lentivirus Using the Engineered Homing Endonuclease Y2 I-AniI
2011

Targeting and Disrupting HIV with Engineered Homing Endonucleases

publication Evidence: moderate

Author Information

Author(s): Aubert Martine, Ryu Byoung Y., Banks Lindsey, Rawlings David J., Scharenberg Andrew M., Jerome Keith R.

Primary Institution: Fred Hutchinson Cancer Research Center

Hypothesis

Can engineered homing endonucleases effectively target and disrupt integrated HIV proviral DNA in latently infected cells?

Conclusion

The study demonstrates that engineered homing endonucleases can selectively target and induce mutations in integrated HIV proviral DNA, potentially disabling the virus.

Supporting Evidence

  • Engineered homing endonucleases can efficiently target integrated HIV proviral DNA.
  • Targeted mutagenesis led to loss of reporter gene expression in the study's model.
  • The approach offers a potential new strategy for curing HIV infection.

Takeaway

Scientists are trying to use special enzymes to break the DNA of HIV inside infected cells, which could help cure people from the virus.

Methodology

The researchers developed an in vitro culture model of viral latency and used engineered homing endonucleases to introduce DNA double-stranded breaks in integrated proviral DNA.

Limitations

The study primarily used in vitro models, and the clinical applicability of the findings remains to be established.

Digital Object Identifier (DOI)

10.1371/journal.pone.0016825

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication